corpus.blog
41,554 blogs · 5,316,985 posts Claim your blog
Record · corpus.blog/posts/01a0875e-1bb1-7222-9d70-4625d8f66ab4

Why Licensing A Dual-Mechanism Anti-IgE Antibody Could Be A Major Opportunity For Cue Biopharma

chaotropy.com · published 17 May 2026

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.

Read the post at chaotropy.com Wayback capture
0blogs citing
First cited
—
Most recent
—
Rank this month
not ranked
External links
16
Words captured
2,809

Cited by

No blog we hold has cited this post yet.

Links from this post

Link
Host
https://www.sec.gov/Archives/edgar/data/1645460/000119312526198588/d128047dex991.htm
sec.gov
https://cuebiopharma.gcs-web.com/node/10321/html
cuebiopharma.gcs-web.com
https://cuebiopharma.gcs-web.com/news-releases/news-release-details/cue-biopharma-reports-first-quarter-2026-financial-results-and?utm_source=organicsocial&utm_medium=twitter&utm_campaign=Q12026-financial-results
cuebiopharma.gcs-web.com
https://www.sec.gov/Archives/edgar/data/0001645460/000119312526198588/d128047d8k.htm
sec.gov
https://www.prnewswire.com/news-releases/united-biopharmas-study-reveals-new-class-of-monoclonal-antibody-for-effective-relief-of-urticaria-symptoms-301600778.html
prnewswire.com
https://www.jci.org/articles/view/157765
jci.org
https://www.nature.com/articles/nbt.1601
nature.com
https://clinicaltrials.gov/study/NCT03632291
clinicaltrials.gov
https://www.nejm.org/doi/full/10.1056/NEJMoa1215372
nejm.org
https://www.hcplive.com/view/phase-3-ligelizumab-not-superior-omalizumab
hcplive.com
https://www.sec.gov/Archives/edgar/data/0001645460/000119312526198588/d128047dex991.htm
sec.gov
https://cheekypint.transistor.fm/18/transcript
cheekypint.transistor.fm
https://www.nejm.org/doi/full/10.1056/NEJMoa2312382
nejm.org
https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-help-reduce-allergic-reactions-multiple-foods-after-accidental
fda.gov
https://www.gsk.com/en-gb/media/press-releases/gsk-enters-agreement-to-acquire-rapt-therapeutics/
gsk.com
https://www.sec.gov/Archives/edgar/data/1673772/000119312524283668/d926285dex991.htm
sec.gov